The 2011 FDA drug approval calendar has been updated.
Transcept Pharmaceuticals(TSPT_)
Drug/indication: Intermezzo for insomnia
Approval decision date: July 14, 2011
This is the second FDA review for Intermezzo following a complete response
letter in October 2009.